POMDOCTOR LIMITED Announces the Termination of Its ADR Program and Trade Class A Ordinary Shares on Nasdaq
Pomdoctor is terminating its ADR program and will list its Class A ordinary shares directly on Nasdaq under the same symbol POM, effective at the market open on October 21, 2026. Simultaneously, the company is executing a 10:1 share consolidation of its Class A and Class B shares; ADS holders will mandatorily exchange 10 ADSs for 3 post-consolidation Class A ordinary shares, with a new CUSIP (G7166T112).
Key figures
- New cusip
- G7166T112
- Effective date
- 2026-10-21
- Reverse split ratio
- 10:1
- Adr to share exchange
- 10 ADSs receive 3 post-consolidation Class A ordinary shares
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.